Citation: | XU Qianzi, LIANG Yueru, ZHAO Zhongwei, SHEN Yan. Population bioequivalence statistical method based on earth mover′s distance for evaluation of particle size distribution consistency of ophthalmic emulsion[J]. Journal of China Pharmaceutical University, 2022, 53(6): 698-704. DOI: 10.11665/j.issn.1000-5048.20220608 |
[1] |
. J China Pharm(中国药房),2016,27(28):3889-3892.
|
[2] |
Tian N,Zhang XY. Fundamental principles for assessment of the quality and efficacy of generic ophthalmic drugs [J]. Chin New Drugs J(中国新药杂志),2020,29(10):1097-1102.
|
[3] |
Guan P,Zhang FC,Zhou HX,et al. Research progress of in vitro population bioequivalence for inhaled drug products[J]. Drug Eval Res(药物评价研究),2019,42(12):2309-2313.
|
[4] |
Sun Y,Xu G,Wng Q. Research on the current regulatory status of FDA on complex generic drugs[J]. Chin New Drugs J(中国新药杂志),2021,30(6):496-500.
|
[5] |
Zang YN,Yu S,Yang J. Related guidelines about in vitro population bioequivalence of locally acting inhaled drug products and nanoparticulate intravenous formulations in FDA[J]. Chin New Drugs J(中国新药杂志),2018,27(10):1116-1121.
|
[6] |
U. S. Food and Drug Administration. Draft guidance on iron sucrose[EB/OL].[
|
[7] |
U. S. Food and Drug Administration.Draft guidance on difluprednate [EB/OL].[
|
[8] |
U. S. Food and Drug Administration. Draft guidance on draft guidance on doxorubicin hydrochloride[EB/OL].[
|
[9] |
U. S. Food and Drug Administration. Draft guidance on dexamethasone; tobramycin[EB/OL].[
|
[10] |
Hu M,Jiang X,Absar M,et al. Equivalence testing of complex particle size distribution profiles based on earth mover's distance[J]. AAPS J,2018,20(3):62.
|
[11] |
U. S. Food and Drug Administration. Draft guidance on cyclosporine[EB/OL]. [
|
[12] |
Rubner Y,Tomasi C,Guibas LJ. The earth mover's distance as a metric for image retrieval[J]. Int J Comput Vis, 2000,40(2):99-121.
|
[13] |
Kumar DS,Priyadarshini A,Shelly B. Earth mover's distance-based tool for rapid screening of cervical cancer using cervigrams[J]. Appl Sci,2022,12(9):4661.
|
[14] |
Ling H,Okada K. An efficient earth mover's distance algorithm for robust histogram comparison[J]. IEEE Trans Pattern Anal Mach Intell,2007,29(5):840-853.
|
[15] |
Lu H,Ma YP. Progress in clinical treatment of xerophthalmia[J].Tianjian Pharm(天津药学),2020,32(04):62-66.
|
[16] |
Dong Y,Hengst L,Hunt R,et al. Evaluating drug distribution and release in ophthalmic emulsions:impact of release conditions[J]. J Control Release,2020,327(2):360-370.
|
[17] |
U. S. Food and Drug Administration. Draft guidance on budesonide[EB/OL].[
|
[18] |
Bang SP,Yeon CY,Adhikari N,et al. Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model [J]. PLoS One,2019,14(11):
|
[19] |
Chow SC,Shao J,Wang H. In vitro bioequivalence testing [J]. Stat Med,2003,22(1):55-68.
|